首页 > 最新文献

Journal of Toxicology最新文献

英文 中文
Dexrazoxane Protects Against Hand-Foot Syndrome-Like Skin Damage in Pegylated Liposomal Doxorubicin-Treated Mice. 右拉萨环保护阿霉素聚乙二醇脂质体处理小鼠的手足综合征样皮肤损伤。
IF 3 Q2 TOXICOLOGY Pub Date : 2026-01-30 eCollection Date: 2026-01-01 DOI: 10.1155/jt/1358796
Kentaro Nishida, Juna Tanaka, Chihiro Hashimoto, Masayuki Tanaka, Takahisa Kuga, Shogo Shigeta, Kazuyuki Kitatani

The anticancer drug pegylated liposomal doxorubicin (PLD) can cause hand-foot syndrome (HFS), a condition that develops in the palms and soles when pressure is frequently applied. Strategies to address HFS are insufficient. Dexrazoxane (DXZ) protects against doxorubicin-induced cardiotoxicity, possibly via reducing topoisomerase (Topo) IIβ levels in myocytes. Previously, we developed a rat model that used three tail-vein doses of PLD to induce HFS-like skin damage. In this study, we generated a simple mouse model of HFS-like skin damage using rubber fastening and PLD treatment to examine potential protective effects from DXZ. Male ddY mice received PLD (16.5 mg/kg) intravenously, with the flank skin compressed by a rubber band for 48 h. DXZ (50 and 250 mg/kg) was administered intraperitoneally twice prior to PLD. Skin tissues were removed on Day 12, fixed, and stained with hematoxylin-eosin to assess epidermal thickening. Western blotting identified the expression of γH2AX (a DNA damage marker) and the doxorubicin targets Topo IIα/β. After Day 8, DXZ (both concentrations) + PLD groups exhibited less skin damage than the PLD group. The PLD group showed greater epidermal layer thickening than both the control and DXZ + PLD groups. γH2AX and Topo IIβ expression increased in the back and flank regions of PLD-treated mice but was suppressed under DXZ + PLD treatment. Although not significant, Topo IIα expression followed an analogous pattern to Topo IIβ expression. In conclusion, we demonstrated that DXZ inhibited PLD-induced skin damage.

抗癌药物聚乙二醇脂质体多柔比星(PLD)可引起手足综合征(HFS),当经常施加压力时,手掌和脚底会出现这种情况。解决HFS的战略是不够的。Dexrazoxane (DXZ)可能通过降低心肌细胞的拓扑异构酶(Topo) i - β水平来防止阿霉素诱导的心脏毒性。在此之前,我们建立了一个大鼠模型,使用三种尾静脉剂量的PLD诱导hfs样皮肤损伤。在这项研究中,我们通过橡胶固定和PLD处理建立了一个简单的hfs样皮肤损伤小鼠模型,以检验DXZ的潜在保护作用。雄性ddY小鼠静脉注射PLD (16.5 mg/kg),并用橡皮筋压迫侧翼皮肤48 h。DXZ(50和250 mg/kg)在PLD前腹腔注射两次。第12天取出皮肤组织,固定,并用苏木精-伊红染色评估表皮增厚。Western blotting检测到DNA损伤标志物γ - h2ax和阿霉素靶蛋白Topo α/β的表达。第8天后,DXZ(两种浓度)+ PLD组的皮肤损伤程度小于PLD组。与对照组和DXZ + PLD组相比,PLD组表皮增厚明显。γ - h2ax和Topo i β在PLD处理小鼠背部和侧翼区域的表达增加,而DXZ + PLD处理小鼠的表达被抑制。虽然不显著,但Topo i α的表达与Topo i β的表达具有类似的模式。总之,我们证明DXZ抑制pld诱导的皮肤损伤。
{"title":"Dexrazoxane Protects Against Hand-Foot Syndrome-Like Skin Damage in Pegylated Liposomal Doxorubicin-Treated Mice.","authors":"Kentaro Nishida, Juna Tanaka, Chihiro Hashimoto, Masayuki Tanaka, Takahisa Kuga, Shogo Shigeta, Kazuyuki Kitatani","doi":"10.1155/jt/1358796","DOIUrl":"10.1155/jt/1358796","url":null,"abstract":"<p><p>The anticancer drug pegylated liposomal doxorubicin (PLD) can cause hand-foot syndrome (HFS), a condition that develops in the palms and soles when pressure is frequently applied. Strategies to address HFS are insufficient. Dexrazoxane (DXZ) protects against doxorubicin-induced cardiotoxicity, possibly via reducing topoisomerase (Topo) IIβ levels in myocytes. Previously, we developed a rat model that used three tail-vein doses of PLD to induce HFS-like skin damage. In this study, we generated a simple mouse model of HFS-like skin damage using rubber fastening and PLD treatment to examine potential protective effects from DXZ. Male ddY mice received PLD (16.5 mg/kg) intravenously, with the flank skin compressed by a rubber band for 48 h. DXZ (50 and 250 mg/kg) was administered intraperitoneally twice prior to PLD. Skin tissues were removed on Day 12, fixed, and stained with hematoxylin-eosin to assess epidermal thickening. Western blotting identified the expression of γH2AX (a DNA damage marker) and the doxorubicin targets Topo IIα/β. After Day 8, DXZ (both concentrations) + PLD groups exhibited less skin damage than the PLD group. The PLD group showed greater epidermal layer thickening than both the control and DXZ + PLD groups. γH2AX and Topo IIβ expression increased in the back and flank regions of PLD-treated mice but was suppressed under DXZ + PLD treatment. Although not significant, Topo IIα expression followed an analogous pattern to Topo IIβ expression. In conclusion, we demonstrated that DXZ inhibited PLD-induced skin damage.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2026 ","pages":"1358796"},"PeriodicalIF":3.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Household Disposal of Unused and Expired Medications: A Cross-Sectional Study on Awareness, Attitude, and Practice in Boma Health Zone, Democratic Republic of Congo, 2024. 家庭处置未使用和过期药物:刚果民主共和国博马卫生区关于意识、态度和实践的横断面研究,2024。
IF 3 Q2 TOXICOLOGY Pub Date : 2026-01-29 eCollection Date: 2026-01-01 DOI: 10.1155/jt/4699974
Christian M Valuvunina, Guillaume M Kiyombo, Joël Nkiama N Konde

Background: The accumulation of unused and expired medications (UEM) in households represents a growing public health and environmental concern, particularly in low-resource settings such as the Democratic Republic of Congo (DRC), where safe disposal infrastructure is limited and regulatory frameworks are weak. In the Boma Health Zone, previous environmental studies have documented pollution of the Kalamu River by solid and liquid waste, including pharmaceuticals, altering its physico-chemical and bacteriological properties. However, no systems for safe medication disposal are available to the public, and empirical data on household UEM disposal practices in the DRC are virtually nonexistent, highlighting the critical need for this research.

Objective: This study assessed the knowledge, attitude, and practice (KAP) regarding UEM disposal among households in the Boma Health Zone, DRC.

Methods: A community-based cross-sectional survey was conducted in April 2024 among 384 households, selected using a four-stage random sampling technique. Data were collected through face-to-face interviews using a structured questionnaire adapted from validated KAP surveys and administered via the Open Data Kit (ODK) app. Reliability was assessed using Cronbach's alpha (α = 0.78). Descriptive statistics and cross-tabulations were performed using STATA version 14. Missing data were checked at entry via built-in ODK validations, and incomplete questionnaires were excluded from analysis.

Results: More than half of households (53.4%, n = 205) stored UEM, primarily due to symptom resolution (70.6%, n = 271). Awareness of safe disposal was poor: only 12.8% (n = 49) had received prior information, and 94.0% (n = 361) were unaware of take-back systems. Overall, 72.9% (n = 276) had low awareness scores. Attitudes were more favorable, with 53.4% (n = 205) displaying a positive attitude and a majority (53.5%, n = 207) supporting mandatory take-back programs. However, unsafe practices dominated: the most common methods for disposing of expired medications were burning (41.7%, n = 160) and disposal in household waste (32.8%, n = 126). Only 4.4% (n = 17) returned expired medicines to a pharmacy, resulting in 98.7% (n = 379) being classified as having poor disposal practices.

Conclusion: Critical gaps in awareness and practice regarding UEM disposal persist in Boma, despite a willingness to engage in safer practices. Urgent, multilevel interventions are needed, including community awareness campaigns, the establishment of accessible take-back programs, and the development of a national pharmaceutical waste management policy.

背景:家庭中未使用和过期药物(UEM)的积累日益成为公共卫生和环境问题,特别是在刚果民主共和国(DRC)等资源匮乏的环境中,安全处置基础设施有限,监管框架薄弱。在博马卫生区,以前的环境研究记录了卡拉穆河受到固体和液体废物(包括药品)的污染,改变了其物理化学和细菌特性。然而,没有向公众提供安全药物处置的系统,而且刚果民主共和国几乎不存在关于家庭UEM处置做法的经验数据,这突出了这项研究的迫切需要。目的:本研究评估了刚果民主共和国博马卫生区家庭对UEM处置的知识、态度和实践(KAP)。方法:采用四阶段随机抽样方法,于2024年4月对384户家庭进行社区横断面调查。通过面对面访谈收集数据,采用结构化问卷,采用经过验证的KAP调查,并通过开放数据工具包(ODK)应用程序进行管理。使用Cronbach's alpha (α = 0.78)评估可靠性。使用STATA版本14进行描述性统计和交叉制表。在输入时通过内置的ODK验证检查缺失的数据,不完整的问卷被排除在分析之外。结果:超过一半的家庭(53.4%,n = 205)储存了UEM,主要原因是症状缓解(70.6%,n = 271)。安全处置意识较差:只有12.8% (n = 49)的人获得了事先信息,94.0% (n = 361)的人不知道回收系统。总体而言,72.9% (n = 276)的认知得分较低。态度更有利,53.4% (n = 205)的人持积极态度,大多数(53.5%,n = 207)的人支持强制回收计划。然而,不安全的做法占主导地位:最常见的处理过期药物的方法是焚烧(41.7%,n = 160)和在生活垃圾中处理(32.8%,n = 126)。只有4.4% (n = 17)将过期药品退回药房,导致98.7% (n = 379)被归类为处置做法不佳。结论:尽管愿意采取更安全的做法,但在Boma,关于UEM处置的认识和实践仍然存在重大差距。需要采取紧急的多层次干预措施,包括开展社区宣传运动,制定可获取的回收方案,以及制定国家药品废物管理政策。
{"title":"Household Disposal of Unused and Expired Medications: A Cross-Sectional Study on Awareness, Attitude, and Practice in Boma Health Zone, Democratic Republic of Congo, 2024.","authors":"Christian M Valuvunina, Guillaume M Kiyombo, Joël Nkiama N Konde","doi":"10.1155/jt/4699974","DOIUrl":"10.1155/jt/4699974","url":null,"abstract":"<p><strong>Background: </strong>The accumulation of unused and expired medications (UEM) in households represents a growing public health and environmental concern, particularly in low-resource settings such as the Democratic Republic of Congo (DRC), where safe disposal infrastructure is limited and regulatory frameworks are weak. In the Boma Health Zone, previous environmental studies have documented pollution of the Kalamu River by solid and liquid waste, including pharmaceuticals, altering its physico-chemical and bacteriological properties. However, no systems for safe medication disposal are available to the public, and empirical data on household UEM disposal practices in the DRC are virtually nonexistent, highlighting the critical need for this research.</p><p><strong>Objective: </strong>This study assessed the knowledge, attitude, and practice (KAP) regarding UEM disposal among households in the Boma Health Zone, DRC.</p><p><strong>Methods: </strong>A community-based cross-sectional survey was conducted in April 2024 among 384 households, selected using a four-stage random sampling technique. Data were collected through face-to-face interviews using a structured questionnaire adapted from validated KAP surveys and administered via the Open Data Kit (ODK) app. Reliability was assessed using Cronbach's alpha (<i>α</i> = 0.78). Descriptive statistics and cross-tabulations were performed using STATA version 14. Missing data were checked at entry via built-in ODK validations, and incomplete questionnaires were excluded from analysis.</p><p><strong>Results: </strong>More than half of households (53.4%, <i>n</i> = 205) stored UEM, primarily due to symptom resolution (70.6%, <i>n</i> = 271). Awareness of safe disposal was poor: only 12.8% (<i>n</i> = 49) had received prior information, and 94.0% (<i>n</i> = 361) were unaware of take-back systems. Overall, 72.9% (<i>n</i> = 276) had low awareness scores. Attitudes were more favorable, with 53.4% (<i>n</i> = 205) displaying a positive attitude and a majority (53.5%, <i>n</i> = 207) supporting mandatory take-back programs. However, unsafe practices dominated: the most common methods for disposing of expired medications were burning (41.7%, <i>n</i> = 160) and disposal in household waste (32.8%, <i>n</i> = 126). Only 4.4% (<i>n</i> = 17) returned expired medicines to a pharmacy, resulting in 98.7% (<i>n</i> = 379) being classified as having poor disposal practices.</p><p><strong>Conclusion: </strong>Critical gaps in awareness and practice regarding UEM disposal persist in Boma, despite a willingness to engage in safer practices. Urgent, multilevel interventions are needed, including community awareness campaigns, the establishment of accessible take-back programs, and the development of a national pharmaceutical waste management policy.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2026 ","pages":"4699974"},"PeriodicalIF":3.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12853071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "The Safety of Soy Leghemoglobin Protein Preparation Derived from Pichia pastoris Expressing a Soy Leghemoglobin Gene from Glycine max: In Vitro and In Vivo Studies". 更正“从毕赤酵母中提取的大豆血红蛋白制剂的安全性:体外和体内研究”。
IF 3 Q2 TOXICOLOGY Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.1155/jt/9862684

[This corrects the article DOI: 10.1155/2023/7398724.].

[这更正了文章DOI: 10.1155/2023/7398724.]
{"title":"Correction to \"The Safety of Soy Leghemoglobin Protein Preparation Derived from <i>Pichia pastoris</i> Expressing a Soy Leghemoglobin Gene from <i>Glycine max</i>: <i>In Vitro</i> and <i>In Vivo</i> Studies\".","authors":"","doi":"10.1155/jt/9862684","DOIUrl":"10.1155/jt/9862684","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2023/7398724.].</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2026 ","pages":"9862684"},"PeriodicalIF":3.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12807582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lower Toxicity of the Essential Oils With Repellent Potential Compared to Diethyltoluamide and Cypermethrin on Porcellio laevis. 具有驱避电位的精油与二乙基甲苯酰胺和氯氰菊酯对青瓷的毒性比较。
IF 3 Q2 TOXICOLOGY Pub Date : 2025-12-30 eCollection Date: 2025-01-01 DOI: 10.1155/jt/6638848
Heber Silva-Díaz, Angie Vilma Serrato-Monja, Emma Vanesa Arriaga-Deza, Lizzie Karen Becerra-Gutiérrez

Objective: To evaluate the acute toxicity of essential oils with repellent potential, diethyltoluamide (DEET), and cypermethrin on Porcellio laevis.

Methods: Randomized preclinical trial with a factorial and controlled arrangement on three essential oils (Eucalyptus globulus, Mentha piperita, and Cymbopogon citratus) at 0.1%, 1%, and 10%, respectively, DEET at 10% and cypermethrin at 0.1%. Each experimental group consisted of 10 specimens, 2-3-mm-long, of P. laevis. Toxicity was measured by specimen mortality at 3, 24, and 48 h postexposure. Nonparametric inferential statistics were used to compare mortality between the groups. The InfoStat/E software, Version 2020, was used for analysis.

Results: Essential oils at concentrations of 0.1% and 1% showed similar toxicity to each other (mortality of 10%-20%) but significantly lower compared to cypermethrin and DEET (mortality of 100%). However, essential oils at 10% reached median mortality rates above 70%. Likewise, similar effects were observed at concentrations of 0.1% and 1.0% and at 24 and 48 h. The LC 50 at 24 h was 7.8% (CI 95%: 5.2-9.8), 6.1% (CI 95%: 4.9-7.4), and 9.8% (CI 95%: 8.9-10.6) for E. globulus, M. piperita, and C. citratus, respectively.

Conclusions: The evaluated essential oils showed lower acute toxicity compared to DEET and cypermethrin, depending on concentration and time.

目的:评价具有驱避潜能的精油、避蚊胺(DEET)和氯氰菊酯对青瓷的急性毒性。方法:三种精油(桉叶、薄荷、香蒲)分别为0.1%、1%和10%,避蚊胺为10%,氯氰菊酯为0.1%,采用因子和对照排列的随机临床前试验。每个实验组10个,长2 ~ 3mm。毒性通过暴露后3、24和48小时的标本死亡率来测定。采用非参数推断统计比较两组间的死亡率。采用2020版InfoStat/E软件进行分析。结果:0.1%和1%浓度的精油毒性相近(死亡率为10% ~ 20%),但与氯氰菊酯和避蚊胺(死亡率为100%)相比显著降低。然而,10%的精油达到了70%以上的中位死亡率。同样,在浓度为0.1%和1.0%以及24和48 h时也观察到类似的效果。24 h的lc50分别为7.8% (CI 95%: 5.2 ~ 9.8)、6.1% (CI 95%: 4.9 ~ 7.4)和9.8% (CI 95%: 8.9 ~ 10.6)。结论:与避蚊胺和氯氰菊酯相比,精油的急性毒性随浓度和时间的不同而降低。
{"title":"Lower Toxicity of the Essential Oils With Repellent Potential Compared to Diethyltoluamide and Cypermethrin on <i>Porcellio laevis</i>.","authors":"Heber Silva-Díaz, Angie Vilma Serrato-Monja, Emma Vanesa Arriaga-Deza, Lizzie Karen Becerra-Gutiérrez","doi":"10.1155/jt/6638848","DOIUrl":"10.1155/jt/6638848","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the acute toxicity of essential oils with repellent potential, diethyltoluamide (DEET), and cypermethrin on <i>Porcellio laevis.</i></p><p><strong>Methods: </strong>Randomized preclinical trial with a factorial and controlled arrangement on three essential oils (<i>Eucalyptus globulus</i>, <i>Mentha piperita</i>, and <i>Cymbopogon citratus</i>) at 0.1%, 1%, and 10%, respectively, DEET at 10% and cypermethrin at 0.1%. Each experimental group consisted of 10 specimens, 2-3-mm-long, of <i>P. laevis</i>. Toxicity was measured by specimen mortality at 3, 24, and 48 h postexposure. Nonparametric inferential statistics were used to compare mortality between the groups. The InfoStat/E software, Version 2020, was used for analysis.</p><p><strong>Results: </strong>Essential oils at concentrations of 0.1% and 1% showed similar toxicity to each other (mortality of 10%-20%) but significantly lower compared to cypermethrin and DEET (mortality of 100%). However, essential oils at 10% reached median mortality rates above 70%. Likewise, similar effects were observed at concentrations of 0.1% and 1.0% and at 24 and 48 h. The LC 50 at 24 h was 7.8% (CI 95%: 5.2-9.8), 6.1% (CI 95%: 4.9-7.4), and 9.8% (CI 95%: 8.9-10.6) for <i>E. globulus</i>, <i>M. piperita</i>, and <i>C. citratus,</i> respectively.</p><p><strong>Conclusions: </strong>The evaluated essential oils showed lower acute toxicity compared to DEET and cypermethrin, depending on concentration and time.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"6638848"},"PeriodicalIF":3.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Particulate Matter 2.5 on Neurological Diseases: Insights Into Pathophysiological and Molecular Mechanisms. 颗粒物质2.5对神经系统疾病的影响:病理生理和分子机制的见解。
IF 3 Q2 TOXICOLOGY Pub Date : 2025-12-30 eCollection Date: 2025-01-01 DOI: 10.1155/jt/5752904
Carmen Rubio, Alejandro López-Landa, Norma Serrano-García, Héctor Romo-Parra, Moisés Rubio-Osornio

Background: Fine particulate matter (PM2.5) has been significantly linked to the progression of various neurological and neurodegenerative diseases.

Objective: This review aims to elucidate the molecular and pathophysiological effects induced by chronic exposure to PM2.5 in neurological and neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, and epilepsy.

Introduction: PM2.5 penetrates the central nervous system (CNS) via the olfactory nerve or by disrupting the blood-brain barrier (BBB), triggering oxidative stress, neuroinflammation, mitochondrial dysfunction, and epigenetic alterations.

Discussion: In Alzheimer's and Parkinson's diseases, PM2.5 exacerbates the accumulation of β-amyloid, hyperphosphorylated tau, and α-synuclein, while in Huntington's disease, it worsens toxicity mediated by mutant huntingtin. In multiple sclerosis, these particles intensify neuroinflammation and axonal damage, whereas in epilepsy, they promote neuronal hyperexcitability and recurrent seizures. These mechanisms contribute to neuronal damage, symptom progression, and functional decline.

Conclusion: This evidence highlights the urgent need for strict environmental policies to reduce PM2.5 exposure and further research to develop therapeutic strategies that mitigate its effects on neurological diseases, thereby improving the health of vulnerable populations.

背景:细颗粒物(PM2.5)与各种神经和神经退行性疾病的进展显著相关。目的:本综述旨在阐明PM2.5慢性暴露对神经系统和神经退行性疾病(包括阿尔茨海默病、帕金森病、亨廷顿病、多发性硬化症和癫痫)的分子和病理生理影响。PM2.5通过嗅觉神经或破坏血脑屏障(BBB)进入中枢神经系统(CNS),引发氧化应激、神经炎症、线粒体功能障碍和表观遗传改变。讨论:在阿尔茨海默病和帕金森病中,PM2.5加剧了β-淀粉样蛋白、过度磷酸化的tau蛋白和α-突触核蛋白的积累,而在亨廷顿病中,PM2.5加重了突变型亨廷顿蛋白介导的毒性。在多发性硬化症中,这些颗粒会加剧神经炎症和轴突损伤,而在癫痫中,它们会促进神经元的高兴奋性和反复发作。这些机制有助于神经元损伤、症状进展和功能下降。结论:这一证据表明,迫切需要制定严格的环境政策来减少PM2.5暴露,并进一步研究制定治疗策略,减轻其对神经系统疾病的影响,从而改善弱势群体的健康。
{"title":"Impact of Particulate Matter 2.5 on Neurological Diseases: Insights Into Pathophysiological and Molecular Mechanisms.","authors":"Carmen Rubio, Alejandro López-Landa, Norma Serrano-García, Héctor Romo-Parra, Moisés Rubio-Osornio","doi":"10.1155/jt/5752904","DOIUrl":"10.1155/jt/5752904","url":null,"abstract":"<p><strong>Background: </strong>Fine particulate matter (PM2.5) has been significantly linked to the progression of various neurological and neurodegenerative diseases.</p><p><strong>Objective: </strong>This review aims to elucidate the molecular and pathophysiological effects induced by chronic exposure to PM2.5 in neurological and neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, and epilepsy.</p><p><strong>Introduction: </strong>PM2.5 penetrates the central nervous system (CNS) via the olfactory nerve or by disrupting the blood-brain barrier (BBB), triggering oxidative stress, neuroinflammation, mitochondrial dysfunction, and epigenetic alterations.</p><p><strong>Discussion: </strong>In Alzheimer's and Parkinson's diseases, PM2.5 exacerbates the accumulation of β-amyloid, hyperphosphorylated tau, and α-synuclein, while in Huntington's disease, it worsens toxicity mediated by mutant huntingtin. In multiple sclerosis, these particles intensify neuroinflammation and axonal damage, whereas in epilepsy, they promote neuronal hyperexcitability and recurrent seizures. These mechanisms contribute to neuronal damage, symptom progression, and functional decline.</p><p><strong>Conclusion: </strong>This evidence highlights the urgent need for strict environmental policies to reduce PM2.5 exposure and further research to develop therapeutic strategies that mitigate its effects on neurological diseases, thereby improving the health of vulnerable populations.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"5752904"},"PeriodicalIF":3.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subacute Oral Toxicity Study of Astragalus Root Water Extract in Rats. 黄芪水提取物对大鼠亚急性口服毒性研究。
IF 3 Q2 TOXICOLOGY Pub Date : 2025-12-17 eCollection Date: 2025-01-01 DOI: 10.1155/jt/7973889
Wei Du, Ping Zhang, Xiaoxian Song, Peilin He, Silan Wu, Jinping Luo, Chonggang Huang, Sixing Huang

Background: Astragalus membranaceus has a long-standing history of use in traditional Chinese medicine (TCM). Despite its extensive historical application and the emerging scientific evidence supporting its medicinal value, the safety of its extracts, particularly concerning subchronic toxicity, remains inadequately characterized.

Aim: This study conducted a subchronic toxicity assessment of Astragalus root water extract (AWE) in Sprague-Dawley rats to evaluate its safety profile.

Methodology: The safety of AWE was evaluated through a 90-day repeated-dose toxicity study, administering a constant daily dose of 47 g of crude drug per kilogram of body weight. The animals were assessed for body weight, food consumption, rectal temperature, and rotarod performance, alongside hematological and biochemical parameters, bone marrow and immune parameters, and underwent gross necropsy and histopathological examination.

Results: No treatment-related mortality, clinical abnormalities, or gross/histopathological changes were observed. Hematological evaluations, clinical biochemical analyses, bone marrow cytology assessments, and spleen immune typing did not reveal any adverse changes. Compared to the control group, rats treated with AWE exhibited a transient decrease in food intake across five different 24-h intervals, as well as a significant reduction in rectal temperature on Day 90. On the 90th day, the latency period on the rotating rod decreased significantly; however, during the subsequent 30-day recovery phase, all parameters returned to baseline levels. Additionally, absolute and relative organ weights, weight gain, and fat mass remained unaffected.

Conclusion: The high-dose administration of AWE did not exhibit significant toxic effects in Sprague-Dawley rats, thereby supporting its safety within a certain dose range.

背景:黄芪在中药中有着悠久的使用历史。尽管其广泛的历史应用和新兴的科学证据支持其药用价值,但其提取物的安全性,特别是在亚慢性毒性方面,仍然没有充分表征。目的:研究黄芪水提取物(Astragalus root water extract, AWE)对Sprague-Dawley大鼠的亚慢性毒性,评价其安全性。方法:通过90天的重复给药毒性研究来评估AWE的安全性,给药剂量为每公斤体重47克生药。评估动物的体重、食量、直肠温度和轮虫性能,以及血液和生化参数、骨髓和免疫参数,并进行大体尸检和组织病理学检查。结果:未观察到与治疗相关的死亡率、临床异常或大体/组织病理学改变。血液学评估、临床生化分析、骨髓细胞学评估和脾脏免疫分型均未发现任何不良变化。与对照组相比,AWE治疗的大鼠在5个不同的24小时间隔内表现出短暂的食物摄入量减少,并且在第90天直肠温度显着降低。第90天,转棒上潜伏期显著缩短;然而,在随后的30天恢复阶段,所有参数都恢复到基线水平。此外,绝对和相对器官重量、体重增加和脂肪量没有受到影响。结论:AWE大剂量给药对Sprague-Dawley大鼠无明显毒性作用,支持其在一定剂量范围内的安全性。
{"title":"Subacute Oral Toxicity Study of Astragalus Root Water Extract in Rats.","authors":"Wei Du, Ping Zhang, Xiaoxian Song, Peilin He, Silan Wu, Jinping Luo, Chonggang Huang, Sixing Huang","doi":"10.1155/jt/7973889","DOIUrl":"10.1155/jt/7973889","url":null,"abstract":"<p><strong>Background: </strong><i>Astragalus membranaceus</i> has a long-standing history of use in traditional Chinese medicine (TCM). Despite its extensive historical application and the emerging scientific evidence supporting its medicinal value, the safety of its extracts, particularly concerning subchronic toxicity, remains inadequately characterized.</p><p><strong>Aim: </strong>This study conducted a subchronic toxicity assessment of Astragalus root water extract (AWE) in Sprague-Dawley rats to evaluate its safety profile.</p><p><strong>Methodology: </strong>The safety of AWE was evaluated through a 90-day repeated-dose toxicity study, administering a constant daily dose of 47 g of crude drug per kilogram of body weight. The animals were assessed for body weight, food consumption, rectal temperature, and rotarod performance, alongside hematological and biochemical parameters, bone marrow and immune parameters, and underwent gross necropsy and histopathological examination.</p><p><strong>Results: </strong>No treatment-related mortality, clinical abnormalities, or gross/histopathological changes were observed. Hematological evaluations, clinical biochemical analyses, bone marrow cytology assessments, and spleen immune typing did not reveal any adverse changes. Compared to the control group, rats treated with AWE exhibited a transient decrease in food intake across five different 24-h intervals, as well as a significant reduction in rectal temperature on Day 90. On the 90th day, the latency period on the rotating rod decreased significantly; however, during the subsequent 30-day recovery phase, all parameters returned to baseline levels. Additionally, absolute and relative organ weights, weight gain, and fat mass remained unaffected.</p><p><strong>Conclusion: </strong>The high-dose administration of AWE did not exhibit significant toxic effects in Sprague-Dawley rats, thereby supporting its safety within a certain dose range.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"7973889"},"PeriodicalIF":3.0,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Diets Supplemented With Low Glycemic Index Starch on Physiology and Locomotor Abilities of Mice. 饲粮中添加低血糖指数淀粉对小鼠生理和运动能力的影响。
IF 3 Q2 TOXICOLOGY Pub Date : 2025-12-12 eCollection Date: 2025-01-01 DOI: 10.1155/jt/9947667
Khanh Son Trinh, Minh Hai Nguyen, Vinh Tien Nguyen

This study explores the effects of a low glycemic index starch (HR0) produced through double thermal retrogradation (4°C/18 h-30°C/6 h), on the physiology and behavior of mice. HR0 starch exhibited low in vitro and in vivo glycemic indexes of 37 and 51, respectively. Mice fed a high-fat diet supplemented with 33% HR0 starch showed significant reductions in body weight compared to those on a high-fat diet. HR0 supplementation normalized fasting plasma glucose levels in mice, preventing the development of diabetes, while all other high-fat diet groups developed diabetic symptoms. Blood lipid analysis indicated that HR0 reduced triglycerides, LDL cholesterol, and total cholesterol levels while increasing HDL cholesterol. Histological examinations showed that HR0 improved the health of liver, kidney, and adipose tissues, notably reducing the incidence of fatty liver disease. Behavioral tests demonstrated that HR0 starch enhanced locomotor activity and reduced anxiety levels. These results suggest that HR0 starch can effectively improve metabolic health and may serve as a beneficial dietary supplement for individuals at risk of obesity, diabetes, and cardiovascular diseases.

本研究探讨了通过双热降解(4°C/18 h-30°C/6 h)产生的低血糖指数淀粉(HR0)对小鼠生理和行为的影响。HR0淀粉体外和体内血糖指数较低,分别为37和51。在高脂肪饮食中添加33% HR0淀粉的小鼠与高脂肪饮食的小鼠相比,体重明显减轻。补充HR0使小鼠的空腹血糖水平正常化,防止糖尿病的发展,而所有其他高脂肪饮食组都出现了糖尿病症状。血脂分析表明,HR0降低了甘油三酯、低密度脂蛋白胆固醇和总胆固醇水平,同时增加了高密度脂蛋白胆固醇。组织学检查显示,HR0改善了肝脏、肾脏和脂肪组织的健康,显著降低了脂肪肝的发病率。行为测试表明,HR0淀粉增强了运动活动,降低了焦虑水平。这些结果表明,HR0淀粉可以有效地改善代谢健康,并可能作为肥胖、糖尿病和心血管疾病高危人群的有益膳食补充剂。
{"title":"Impact of Diets Supplemented With Low Glycemic Index Starch on Physiology and Locomotor Abilities of Mice.","authors":"Khanh Son Trinh, Minh Hai Nguyen, Vinh Tien Nguyen","doi":"10.1155/jt/9947667","DOIUrl":"10.1155/jt/9947667","url":null,"abstract":"<p><p>This study explores the effects of a low glycemic index starch (HR0) produced through double thermal retrogradation (4°C/18 h-30°C/6 h), on the physiology and behavior of mice. HR0 starch exhibited low in vitro and in vivo glycemic indexes of 37 and 51, respectively. Mice fed a high-fat diet supplemented with 33% HR0 starch showed significant reductions in body weight compared to those on a high-fat diet. HR0 supplementation normalized fasting plasma glucose levels in mice, preventing the development of diabetes, while all other high-fat diet groups developed diabetic symptoms. Blood lipid analysis indicated that HR0 reduced triglycerides, LDL cholesterol, and total cholesterol levels while increasing HDL cholesterol. Histological examinations showed that HR0 improved the health of liver, kidney, and adipose tissues, notably reducing the incidence of fatty liver disease. Behavioral tests demonstrated that HR0 starch enhanced locomotor activity and reduced anxiety levels. These results suggest that HR0 starch can effectively improve metabolic health and may serve as a beneficial dietary supplement for individuals at risk of obesity, diabetes, and cardiovascular diseases.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"9947667"},"PeriodicalIF":3.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacokinetics and Toxicity Overview of Active Compounds Berberine, Palmatine, and Jatrorrhizine From Fibraurea tinctoria Lour: Drug-Likeness, ADMET Prediction, and In Vivo Extract Toxicity Assessment. 活性化合物小檗碱、棕榈碱和黄毒根碱的药代动力学和毒性综述:药物相似性、ADMET预测和体内提取物毒性评估。
IF 3 Q2 TOXICOLOGY Pub Date : 2025-12-11 eCollection Date: 2025-01-01 DOI: 10.1155/jt/7251602
Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa, Sriwidodo Sriwidodo

Fibraurea tinctoria Lour has long been used by the indigenous ethnic groups of Kalimantan in the traditional treatment of malaria, jaundice, and diabetes mellitus. This study aimed to evaluate the drug-likeness and ADMET properties of the active compounds berberine, palmatine, and jatrorrhizine and to assess the acute toxicity of the plant extract using in silico and in vivo approaches. In silico analysis was performed using the pkCSM, ProTox-II, and SwissADME online web servers to predict drug-likeness and ADMET of compounds from Fibraurea tinctoria Lour. The in vivo acute toxicity of the extract was evaluated according to the Organization for Economic Cooperation and Development (OECD) 425 guideline. In silico studies have demonstrated that berberine, palmatine, and jatrorrhizine exhibit favorable drug-likeness and pharmacokinetic properties but indicate potential oral toxicity. In contrast, the in vivo acute toxicity study revealed no toxicity or adverse effects, with an LD50 greater than 5000 mg/kg. These findings indicate that despite the in silico prediction showing the potential toxicity of these three compounds, the extract exhibited relative safety based on in vivo tests and has the potential for further pharmacological development.

长期以来,加里曼丹的土著民族一直使用纤维脲治疗疟疾、黄疸和糖尿病。本研究旨在评价活性化合物小檗碱、棕榈碱和麻草根碱的药物相似性和ADMET特性,并采用硅和体内方法评估植物提取物的急性毒性。使用pkCSM、ProTox-II和SwissADME在线web服务器进行计算机分析,预测来自纤维脲(Fibraurea tinctoria Lour)化合物的药物相似性和ADMET。根据经济合作与发展组织(OECD)第425号准则对提取物的体内急性毒性进行了评价。计算机研究表明,小檗碱、棕榈碱和黄根碱表现出良好的药物相似性和药代动力学特性,但表明潜在的口服毒性。相比之下,体内急性毒性研究显示无毒性或不良反应,LD50大于5000mg /kg。这些发现表明,尽管计算机预测显示这三种化合物的潜在毒性,但基于体内试验的提取物显示出相对安全性,并且具有进一步药理开发的潜力。
{"title":"Pharmacokinetics and Toxicity Overview of Active Compounds Berberine, Palmatine, and Jatrorrhizine From <i>Fibraurea tinctoria</i> Lour: Drug-Likeness, ADMET Prediction, and In Vivo Extract Toxicity Assessment.","authors":"Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa, Sriwidodo Sriwidodo","doi":"10.1155/jt/7251602","DOIUrl":"10.1155/jt/7251602","url":null,"abstract":"<p><p><i>Fibraurea tinctoria</i> Lour has long been used by the indigenous ethnic groups of Kalimantan in the traditional treatment of malaria, jaundice, and diabetes mellitus. This study aimed to evaluate the drug-likeness and ADMET properties of the active compounds berberine, palmatine, and jatrorrhizine and to assess the acute toxicity of the plant extract using in silico and in vivo approaches. In silico analysis was performed using the pkCSM, ProTox-II, and SwissADME online web servers to predict drug-likeness and ADMET of compounds from <i>Fibraurea tinctoria</i> Lour. The in vivo acute toxicity of the extract was evaluated according to the Organization for Economic Cooperation and Development (OECD) 425 guideline. In silico studies have demonstrated that berberine, palmatine, and jatrorrhizine exhibit favorable drug-likeness and pharmacokinetic properties but indicate potential oral toxicity. In contrast, the in vivo acute toxicity study revealed no toxicity or adverse effects, with an LD<sub>50</sub> greater than 5000 mg/kg. These findings indicate that despite the in silico prediction showing the potential toxicity of these three compounds, the extract exhibited relative safety based on in vivo tests and has the potential for further pharmacological development.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"7251602"},"PeriodicalIF":3.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145910588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microplastic Exposure and Its Dual Impact on Metabolic Syndrome and Pathways of Colorectal Carcinogenesis: A Systematic Review of Epidemiological, Experimental, and Mechanistic Evidence. 微塑料暴露及其对代谢综合征和结直肠癌发生途径的双重影响:流行病学、实验和机制证据的系统综述。
IF 3 Q2 TOXICOLOGY Pub Date : 2025-12-09 eCollection Date: 2025-01-01 DOI: 10.1155/jt/5569113
Abdullah Faisal Albukhari

Background: Microplastics (MPs) and the endocrine-disrupting chemicals associated with them, including bisphenol A (BPA) and phthalates, have been identified as potential factors contributing to the increasing rates of metabolic syndrome (MetS) and colorectal carcinogenesis. Despite rising concerns in this area, a thorough synthesis of the mechanistic and epidemiological data connecting MPs to these health issues is currently absent. For consistency in this review, early-onset colorectal cancer is defined as colorectal cancer diagnosed before the age of 50 years, in line with recent epidemiological studies. Chronic exposure to MPs is defined as sustained exposure lasting at least 8 weeks in animal models or multiple years in human observational studies. These standardized definitions ensure clarity when comparing outcomes across diverse study designs.

Objective: This systematic review aims to evaluate current human, animal, and in vitro evidence on the dual impact of MP exposure on metabolic dysregulation and pathways involved in colorectal carcinogenesis.

Methods: A systematic search was performed across PubMed, Scopus, Web of Science, and EMBASE in accordance with PRISMA 2020 guidelines. The review incorporated 45 studies: 18 observational studies involving humans, 17 animal studies, and 10 in vitro investigations. The outcomes analyzed included components of MetS, precursors to colonic neoplasia, and relevant biological mechanisms.

Results: Exposure to MPs correlated with an increased risk of insulin resistance, obesity, and dyslipidemia. It also contributed to heightened inflammatory responses, alterations in gut microbiota composition, and dysfunction of the epithelial barrier. Furthermore, chronic exposure led to colonic inflammation and an elevation in tumorigenic markers, such as β-catenin (a key oncogenic protein in the Wnt signaling pathway) and COX-2 (an inflammatory enzyme implicated in tumor progression).

Conclusion: The results indicate a biologically plausible connection between MP exposure and the development of both MetS and colorectal carcinogenesis pathways, rather than a direct clinical association with early-onset colorectal cancer.

背景:微塑料(MPs)和与之相关的内分泌干扰化学物质,包括双酚A (BPA)和邻苯二甲酸盐,已被确定为导致代谢综合征(MetS)和结直肠癌发生率上升的潜在因素。尽管这一领域的关注日益增加,但目前缺乏将MPs与这些健康问题联系起来的机制和流行病学数据的全面综合。为了本综述的一致性,早发性结直肠癌被定义为50岁之前诊断的结直肠癌,与最近的流行病学研究一致。慢性暴露于多磺酸粘多糖被定义为在动物模型中持续暴露至少8周或在人类观察研究中持续暴露多年。这些标准化的定义确保了在比较不同研究设计的结果时的清晰度。目的:本系统综述旨在评估目前人类、动物和体外证据,以证明MP暴露对结直肠癌发生中代谢失调和途径的双重影响。方法:根据PRISMA 2020指南,在PubMed、Scopus、Web of Science和EMBASE上进行系统检索。该综述纳入了45项研究:18项涉及人类的观察性研究,17项动物研究和10项体外研究。结果分析包括MetS的成分、结肠肿瘤的前体和相关的生物学机制。结果:暴露于MPs与胰岛素抵抗、肥胖和血脂异常的风险增加相关。它还导致炎症反应加剧、肠道微生物群组成改变和上皮屏障功能障碍。此外,慢性暴露导致结肠炎症和致瘤标志物的升高,如β-catenin (Wnt信号通路中的关键致癌蛋白)和COX-2(一种与肿瘤进展有关的炎症酶)。结论:这些结果表明,MP暴露与met和结直肠癌发生途径之间存在生物学上合理的联系,而不是与早发性结直肠癌的直接临床关联。
{"title":"Microplastic Exposure and Its Dual Impact on Metabolic Syndrome and Pathways of Colorectal Carcinogenesis: A Systematic Review of Epidemiological, Experimental, and Mechanistic Evidence.","authors":"Abdullah Faisal Albukhari","doi":"10.1155/jt/5569113","DOIUrl":"10.1155/jt/5569113","url":null,"abstract":"<p><strong>Background: </strong>Microplastics (MPs) and the endocrine-disrupting chemicals associated with them, including bisphenol A (BPA) and phthalates, have been identified as potential factors contributing to the increasing rates of metabolic syndrome (MetS) and colorectal carcinogenesis. Despite rising concerns in this area, a thorough synthesis of the mechanistic and epidemiological data connecting MPs to these health issues is currently absent. For consistency in this review, early-onset colorectal cancer is defined as colorectal cancer diagnosed before the age of 50 years, in line with recent epidemiological studies. Chronic exposure to MPs is defined as sustained exposure lasting at least 8 weeks in animal models or multiple years in human observational studies. These standardized definitions ensure clarity when comparing outcomes across diverse study designs.</p><p><strong>Objective: </strong>This systematic review aims to evaluate current human, animal, and <i>in vitro</i> evidence on the dual impact of MP exposure on metabolic dysregulation and pathways involved in colorectal carcinogenesis.</p><p><strong>Methods: </strong>A systematic search was performed across PubMed, Scopus, Web of Science, and EMBASE in accordance with PRISMA 2020 guidelines. The review incorporated 45 studies: 18 observational studies involving humans, 17 animal studies, and 10 <i>in vitro</i> investigations. The outcomes analyzed included components of MetS, precursors to colonic neoplasia, and relevant biological mechanisms.</p><p><strong>Results: </strong>Exposure to MPs correlated with an increased risk of insulin resistance, obesity, and dyslipidemia. It also contributed to heightened inflammatory responses, alterations in gut microbiota composition, and dysfunction of the epithelial barrier. Furthermore, chronic exposure led to colonic inflammation and an elevation in tumorigenic markers, such as β-catenin (a key oncogenic protein in the Wnt signaling pathway) and COX-2 (an inflammatory enzyme implicated in tumor progression).</p><p><strong>Conclusion: </strong>The results indicate a biologically plausible connection between MP exposure and the development of both MetS and colorectal carcinogenesis pathways, rather than a direct clinical association with early-onset colorectal cancer.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"5569113"},"PeriodicalIF":3.0,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical Warfare Through the Ages: A Systematic Review From Antiquity to the Present. 古往今来的化学战:从古代到现在的系统回顾。
IF 3 Q2 TOXICOLOGY Pub Date : 2025-11-20 eCollection Date: 2025-01-01 DOI: 10.1155/jt/7363632
Damian Alexander Honeyman, David James Heslop, Samsung Lim, Chandini Raina MacIntyre

Chemical warfare means the use of chemical agents that have direct toxic effects on animals, plants and humans, as weapons. The first documented use of a chemical agent for warfare purposes occurred in ancient times around 10,000 BCE in South Africa when weapons were dipped in chemicals and then used to attack and defend from enemies. However, much of the evidence lacks detail to provide thorough accounts of such events. Nevertheless, we aimed to systematically gather the most comprehensive account of all publicly known incidents involving chemical weapons throughout history. We identified 121 instances of chemical weapon use between 10,000 BCE and October 2023 spanning 49 countries and causing at minimum 2,110,360 injuries and 2,930,769 deaths. Across the 121 incidents, at least 165 chemical agents were used. Of the known chemical agents, the top three were sulphur mustard (n = 16, 12.1%), hydrogen cyanide (n = 12, 7.3%) and chlorine gas (n = 11, 6.7%). Of the known chemical classes, the top three used were vesicants (blistering agents) (n = 31, 18.8%), choking (pulmonary) agents (n = 18, 10.9%) and nerve agents (n = 18, 10.9%). If a chemical agent was not reported, the chemical class was reported as unknown (n = 35, 21.2%). A small number of chemical weapons were used that fell outside of the main categories of agents (n = 20, 12.1%). Chemical weapons remain a serious concern locally and globally, and there are few data on the global epidemiology of such incidents. Prevention, early detection and rapid response are key and can be enabled by global surveillance for chemical incidents.

化学战是指使用对动物、植物和人类有直接毒性作用的化学制剂作为武器。有记载的第一次将化学制剂用于战争目的发生在公元前1万年左右的古代南非,当时武器浸在化学物质中,然后用于攻击和防御敌人。然而,许多证据缺乏细节,无法对此类事件进行全面描述。然而,我们的目标是系统地收集历史上所有公开知道的涉及化学武器的事件的最全面的说明。在公元前1万年至2023年10月期间,我们确定了121起使用化学武器的事件,涉及49个国家,造成至少2110360人受伤,2930769人死亡。在121起事件中,至少使用了165种化学制剂。在已知的化学制剂中,前三位分别是硫芥(n = 16, 12.1%)、氰化氢(n = 12, 7.3%)和氯气(n = 11, 6.7%)。在已知的化学类别中,使用最多的前三名是泡腾剂(起泡剂)(n = 31, 18.8%)、窒息(肺)剂(n = 18, 10.9%)和神经毒剂(n = 18, 10.9%)。如果一种化学制剂未被报告,则该化学品类别被报告为未知(n = 35, 21.2%)。少数化学武器的使用不属于主要药剂类别(n = 20, 12.1%)。化学武器仍然是当地和全球的一个严重问题,关于这类事件的全球流行病学数据很少。预防、早期发现和快速反应是关键,可以通过对化学品事件的全球监测来实现。
{"title":"Chemical Warfare Through the Ages: A Systematic Review From Antiquity to the Present.","authors":"Damian Alexander Honeyman, David James Heslop, Samsung Lim, Chandini Raina MacIntyre","doi":"10.1155/jt/7363632","DOIUrl":"10.1155/jt/7363632","url":null,"abstract":"<p><p>Chemical warfare means the use of chemical agents that have direct toxic effects on animals, plants and humans, as weapons. The first documented use of a chemical agent for warfare purposes occurred in ancient times around 10,000 BCE in South Africa when weapons were dipped in chemicals and then used to attack and defend from enemies. However, much of the evidence lacks detail to provide thorough accounts of such events. Nevertheless, we aimed to systematically gather the most comprehensive account of all publicly known incidents involving chemical weapons throughout history. We identified 121 instances of chemical weapon use between 10,000 BCE and October 2023 spanning 49 countries and causing at minimum 2,110,360 injuries and 2,930,769 deaths. Across the 121 incidents, at least 165 chemical agents were used. Of the known chemical agents, the top three were sulphur mustard (<i>n</i> = 16, 12.1%), hydrogen cyanide (<i>n</i> = 12, 7.3%) and chlorine gas (<i>n</i> = 11, 6.7%). Of the known chemical classes, the top three used were vesicants (blistering agents) (<i>n</i> = 31, 18.8%), choking (pulmonary) agents (<i>n</i> = 18, 10.9%) and nerve agents (<i>n</i> = 18, 10.9%). If a chemical agent was not reported, the chemical class was reported as unknown (<i>n</i> = 35, 21.2%). A small number of chemical weapons were used that fell outside of the main categories of agents (<i>n</i> = 20, 12.1%). Chemical weapons remain a serious concern locally and globally, and there are few data on the global epidemiology of such incidents. Prevention, early detection and rapid response are key and can be enabled by global surveillance for chemical incidents.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"7363632"},"PeriodicalIF":3.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12660622/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Toxicology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1